Humana Inc. (NYSE:HUM) Shares Sold by Waldron Private Wealth LLC

Waldron Private Wealth LLC decreased its stake in Humana Inc. (NYSE:HUM) by 9.8% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 467 shares of the insurance provider’s stock after selling 51 shares during the period. Waldron Private Wealth LLC’s holdings in Humana were worth $213,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Gradient Investments LLC grew its stake in Humana by 200.0% during the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after buying an additional 40 shares during the last quarter. Sunbelt Securities Inc. purchased a new stake in Humana in the 1st quarter valued at approximately $28,000. Householder Group Estate & Retirement Specialist LLC acquired a new position in Humana during the 3rd quarter worth approximately $39,000. Nvwm LLC lifted its holdings in shares of Humana by 41.0% in the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after buying an additional 25 shares during the period. Finally, Turtle Creek Wealth Advisors LLC acquired a new position in Humana during the fourth quarter worth $55,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently commented on HUM shares. Stephens decreased their price objective on shares of Humana from $550.00 to $430.00 and set an “overweight” rating on the stock in a report on Friday, January 26th. UBS Group reaffirmed a “neutral” rating and issued a $370.00 target price (down previously from $530.00) on shares of Humana in a research note on Friday, January 26th. TheStreet downgraded Humana from a “b” rating to a “c+” rating in a research report on Monday, January 8th. Argus downgraded shares of Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, March 13th. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $391.00 price objective on shares of Humana in a research report on Wednesday, April 10th. Eleven investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $465.42.

Humana Trading Up 0.9 %

NYSE:HUM opened at $317.42 on Wednesday. Humana Inc. has a 12 month low of $299.23 and a 12 month high of $541.21. The business’s 50-day moving average is $345.31 and its two-hundred day moving average is $426.43. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.59 and a quick ratio of 1.59. The firm has a market capitalization of $38.30 billion, a PE ratio of 16.02, a price-to-earnings-growth ratio of 1.84 and a beta of 0.45.

Humana (NYSE:HUM) last released its quarterly earnings results on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.87). Humana had a return on equity of 19.44% and a net margin of 2.34%. The company had revenue of $26.46 billion during the quarter, compared to analysts’ expectations of $25.47 billion. During the same quarter in the prior year, the company earned $1.62 EPS. The firm’s revenue was up 17.9% compared to the same quarter last year. Research analysts predict that Humana Inc. will post 16.06 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be given a $0.885 dividend. The ex-dividend date is Wednesday, March 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.12%. Humana’s payout ratio is currently 17.86%.

Insider Buying and Selling

In related news, Director Jorge S. Mesquita purchased 545 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was acquired at an average price of $367.09 per share, with a total value of $200,064.05. Following the completion of the transaction, the director now owns 2,578 shares of the company’s stock, valued at $946,358.02. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.29% of the company’s stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.